University of California, San Diego

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).

775 total trials 143 currently recruiting 499 completed early-phase tilt top decile by trial count

University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.

University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.

Top-decile sponsor footprint

University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

775 total, page 16 of 16

COMPLETED Phase 2

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

NCT00214890

COMPLETED NA

Smokers' Quitline for Asian Language Speakers

NCT01248832

COMPLETED Phase 1

Infliximab (Remicade) for Patients With Acute Kawasaki Disease

NCT00271570

COMPLETED NA

Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis

NCT00746889

COMPLETED

Stroke Team Remote Evaluation Using a Digital Observation Camera

NCT00283868

COMPLETED NA

Comparison of Video Consent Versus Routine Consent for Participation in Research Studies

NCT00430391

COMPLETED

OTIS Humira Pregnancy Registry

NCT01086059

COMPLETED Phase 1

Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke

NCT00283088

COMPLETED NA

Cognitive Training for Patients With Schizophrenia

NCT01521026

TERMINATED Phase 2

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

NCT00074269

COMPLETED

The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia

NCT00247637

COMPLETED NA

Comparison of Acetaminophen With Codeine and Ibuprofen for Children With Injuries

NCT00474721

COMPLETED Phase 2

Rehabilitative Training for Older People With Schizophrenia

NCT00071591

COMPLETED Phase 3

Telephone Counseling for Pregnant Smokers

NCT02144883

COMPLETED NA

PACE+: Counseling Adolescents for Exercise and Nutrition

NCT01657422

COMPLETED NA

Effect of Treating Sleep Apnea on Cognition in Patients With Dementia

NCT00477828

COMPLETED Phase 4

Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels

NCT00330980

COMPLETED Phase 1

Movement Disorders Caused by Antipsychotic Drugs in Older Patients

NCT00255879

COMPLETED Phase 2

Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia

NCT00004493

COMPLETED NA

Problem Solving Therapy for Prostate Cancer Spousal Caregivers

NCT02085096

COMPLETED NA

TIPS Versus Portacaval Shunt for Acute Bleeding Varices in Cirrhosis

NCT00734227

COMPLETED

Women's Healthy Eating and Living Study

NCT00003787

COMPLETED NA

San Diego Bleeding Esophageal Varices Study

NCT00690027

COMPLETED NA

Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices

NCT00820781

COMPLETED Phase 2

Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine

NCT00291512

← Previous Page 16 of 16

Phase Distribution

PhaseTrial count
Phase 1 80
Phase 2 90
Phase 3 22
Phase 4 82

What is open in the University of California, San Diego pipeline

143 recruiting of 775 indexed (18% open); 499 completed (64%).

Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).

Top condition: Anorexia Nervosa (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, San Diego: open-pipeline peers nationwide

Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of California, San DiegoDana-Farber Cancer InstituteMedical University of South CarolinaUniversity of ChicagoUniversity of UtahNeurocrine BiosciencesThomas Jefferson UniversityAbramson Cancer Center at Penn MedicineUniversity of Maryland, Baltimore
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 775 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

What to do with this University of California, San Diego page

775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.

  • 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.